vimarsana.com
  1. Home
  2. Live Updates
  3. Tab Cel Would - Breaking News

Latest Breaking News On - Tab cel would - Page 1 : vimarsana.com

Pierre Fabre Laboratories announces the submission by Atara Biotherapeutics of Tabelecleucel (Tab-cel®) Biologics License Application for treatment of Epstein-Barr Virus Positive Post-Transplant Lymphoproliferative Disease with U S FDA

CASTRES, France, May 20, 2024 /PRNewswire/ Pierre Fabre Laboratories today announce the submission by Atara Biotherapeutics (ATARA), a leader in T-cell

United statesMidi pyréesPierre fabreAdriana herreraLaurence marchalPierre fabre pharmaceuticals incDrug administrationFirst allogeneict cell therapyTab cel wouldFirst approved therapyPierre fabre pharmaceuticalsPierre fabre laboratoriesBiologics license applicationChief executive officerPierre fabre medical careLaboratories media contact

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.